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A B S T R A C T
Heat shock proteins (HSPs) are a large family of ubiquitously expressed proteins with diverse functions, in-
cluding protein assembly and folding/unfolding. These proteins have been associated with the progression of
various gastrointestinal tumours. Dysregulation of cellular redox has also been associated with gastrointestinal
carcinogenesis, however, a link between HSPs and dysregulation of cellular redox in carcinogenesis remains
unclear. In this study, we analysed mRNA co-expression and methylation patterns, as well as performed survival
analysis and gene set enrichment analysis, on gastrointestinal cancer data sets (oesophageal, stomach and col-
orectal carcinomas) to determine whether HSP activity and cellular redox dysregulation are linked. A wide-
spread relationship between HSPs and cellular redox was identified, with specific combinatorial co-expression
patterns demonstrated to significantly alter patient survival outcomes. This comprehensive analysis provides the
foundation for future studies aimed at deciphering the mechanisms of cooperativity between HSPs and redox
regulatory enzymes, which may be a target for future therapeutic intervention for gastrointestinal tumours.
1. Introduction
Heat shock proteins (HSPs) are a highly conserved, ubiquitously
expressed family of proteins, that act as molecular chaperones to cor-
rectly fold a new polypeptide chain, or support the refolding of da-
maged proteins [1]. HSPs have been implicated in a variety of cellular
processes, including cell cycle regulation, organelle trafficking, and
signal transduction [2]. Interestingly, experimental evidence indicates
that stress-induced activation of HSPs endows cells with a survival
advantage by mechanism(s) that, on the one hand, activate pro-survival
networks, and on the other, inhibit apoptotic execution [3]. These at-
tributes and the association with pro-inflammatory signalling lend
credence to the involvement of HSPs in promoting carcinogenesis and
its progression [4,5]. Along similar lines, the differential expression of
various HSP family members and dysregulation of redox homeostasis
have been individually implicated in tumorigenesis, particularly in-
volving the gastrointestinal (GI) tract [6,7]. However, the interplay
between HSPs and redox regulation in the setting of GI cancers is less
widely understood.
HSPs are divided into five families, including the DNAJ (HSP40)
family, the HSPB (small heat shock protein family), the HSP90/HSPC
family, chaperonins (HSPD/E and CCT) and the HSP70 superfamily,
containing the HSPA (HSP70) and HSPH (HSP110) subfamilies [8].
These families mainly differ in their functions and cellular localisations.
The DNAJ/HSP40 family primarily function by stimulating the ATPase
activity of HSP70s [9], while the HSP70 family has been implicated in
most aspects of protein folding, import, recovery from aggregation and
drug resistance in cancer [10]. HSP90 is involved in many cellular
processes, including DNA repair [11], and has been implicated in a
variety of neoplasia [12]. The HSPB family, in particular HSP27, has
been shown to be associated with several human cancers, as it promotes
epithelial to mesenchymal transition (EMT) [13,14], blocks apoptotic
signalling [15], and triggers activation of oncogenic transcription fac-
tors such as NF-κB [13] and mitogen activated protein kinases (MAPK)
[16], independent of their ATP hydrolysis function [17]. Chaperonins,
or CCT (chaperonin containing TCP-1) proteins, are ring complexes
encompassing a central cavity; this allows protein folding in a shielded
environment. They can be divided into two groups: Group 1 (HSPD),
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that are present in the mitochondria, and Group 2, that are localized to
the cytosol [18].
An imbalance in intracellular redox conditions can promote or in-
hibit tumour growth [19]. This is dependent on a tight balance between
the different reactive oxygen species present within the cell [20]. In-
creased superoxide (O2-) production, favouring a pro-oxidant milieu,
has been demonstrated to act as a pro-survival signal in some cancers
[21–23], while increased peroxides, particularly hydrogen peroxide
(H2O2), can initiate death signalling, leading to apoptosis [24,25].
There is a close relationship between intracellular redox and HSPs.
Protein folding, specifically, disulfide bond formation, is an oxidative
process and generates ROS, primarily in the form of H2O2 [26,27].
Dysregulation of protein folding can cause oxidative stress and stimu-
late the unfolded protein response (UPR), which is dependent on HSP
proteins [28]. Furthermore, ROS-mediated DNA oxidation and lipid
peroxidation can result in the induction of HSP synthesis [29]. For
example, a redox-regulated HSP family member, HSP33, functions as a
cellular protective agent against oxidative stress in prokaryotes; a co-
ordinated zinc ion of HSP33 is released from the protein following the
oxidation of cysteine residues by H2O2 to activate the protein [30].
Mammalian HSP1 has been reported to exhibit a similar oxidative stress
response to prokaryotic HSP33. Two conserved cysteine residues near
the DNA-binding domain are crucial for the formation of higher order
homomultimers, required for target gene transcription and protection
from oxidative stress [31]. These redox-mediated reversible reactions
are critical for the activity of HSP33 and HSP1 and demonstrate the
importance of cellular redox state on HSP function.
Datasets describing molecular and clinical features of patient tu-
mours have been made publicly available through consortia such as The
Cancer Genome Atlas (TCGA), accessible through websites such as
cBioPortal [32,33]. These datasets contain large numbers of patient
samples across many cancer types, linking mutation, copy-number al-
terations, transcriptomic, proteomic and methylomic data with clinical
attributes, including survival outcomes, age, gender and therapeutic
interventions. These large datasets have provided the foundation for
studies that have resulted in the successful identification of biomarkers,
development of in vivo models and the identification of drug candidates
[34–36]. The generation of a gene signature in response to different
drugs using only public databases enabled the repurposing of niclosa-
mide ethanolamine, previously used as an anti-helminthic, as an anti-
tumour agent against hepatocellular carcinoma (HCC); this molecule
disrupted the interaction between cell division cycle 37 and HSP90, and
was effective at reducing tumour burden in vivo [34]. Similarly, an in
silico approach using public datasets identified protein tyrosine kinase
PTK7 as a potential oncogenic driver in non-small cell lung cancer
(NSCLC); these findings were validated in vitro and in vivo, where PTK7
was found to regulate MKK7-JNK signalling, indicating its utility as a
potential therapeutic target [35].
In this study, we identified a range of previously unreported genes
in GI cancer patients – specifically, oesophageal, stomach and colorectal
cancers – that resulted in significantly altered survival outcomes when
differentially expressed. We have also identified new combinations of
HSP and redox genes that, when differentially expressed, predicted
overall and disease-free survival in the selected cohorts. These genes
may represent clinically relevant targets for use as biomarkers in
monitoring disease progression and severity, as well as offering po-
tential interest for the development of new cancer therapeutics.
2. Methods
2.1. Data collection
Gastrointestinal carcinoma datasets were obtained from the relevant
TCGA studies via cBioPortal [33] in November 2017, specifically the
oesophageal carcinoma [37], stomach adenocarcinoma [38] and col-
orectal adenocarcinoma data sets [39]. Based on the families set out in
the guidelines for the nomenclature for HSPs, we examined 96 HSP
genes [8] and 30 cancer-associated genes involved in redox generation
and detoxification [40] in a range of analyses, including co-expression
of HSP and redox regulator genes, correlation of gene methylation and
expression at different cancer stages, survival, and enrichment of other
gene families in susceptible populations. For all analyses, the three
cancer types were analysed separately. Analysis was facilitated via Perl
scripts developed in-house.
2.2. Co-expression and methylation analysis
For co-expression analyses, Spearman's ρ values were calculated
using mRNA expression z-scores (calculated from RNA Seq V2 RSEM
data, compared to the expression distribution of each gene in tumours
that are diploid for that gene, as provided by cBioPortal) for all gene
combinations, using all patient data. Spearman's ρ was also used to
assess correlation between methylation β-values (from HM450 data)
and mRNA expression z-scores for all genes, separating patient data by
tumour stage; positive ρ values indicate that increased gene methyla-
tion can be correlated to increased gene expression, while conversely, a
negative ρ values that increased gene methylation can be correlated to
decreased gene expression.
2.3. Survival analysis
Survival analysis was performed for selected patient groups meeting
specific criteria. Patients were categorized as “high” or “low” expressers
of genes, using an absolute mRNA expression z-score cutoff of 0.75;
such groups required a minimum of 10 patients before further analysis
was performed. The log-rank test was used to assess whether differences
in survival were statistically significant; comparisons yielding p-values
less than 0.05 were selected as statistically significant. Patient groups
with single gene high/low phenotypes were assessed, as well as groups
with two gene high/low phenotypes.
2.4. Gene set enrichment analysis
For patient groups with phenotypes affording significant differences
in survival, gene set enrichment analysis (GSEA) was performed using
the GSEA software [41,42]. The lists of patients corresponding to each
patient group for comparison were manually provided to GSEA to
create phenotypes for analysis. GO gene sets [43] were used in the
analysis. Gene sets affording p-values less than 0.05 and q-values (false
discovery rates) of less than 0.25 were selected as being significantly
altered between the patient groups. The remaining gene sets were then
ranked by the GSEA normalised enrichment score (NES), and up to the
top 350 ranked gene sets were analysed using REVIGO [44] to further
summarize the biological importance of the identified gene sets. NESs
for each gene set were supplied to REVIGO as a measure of the relative
significance of each gene set. The human database was used and al-
lowed similarity of output gene sets was set to tiny (0.4). The SimRel
semantic similarity measure was used [45].
3. Results
3.1. Analysis of co-expression patterns of heat shock proteins and redox
regulator genes in GI carcinomas
To determine co-expression patterns of the 126 HSP and redox
regulator genes, we calculated Spearman's rank correlation coefficient
(ρ) for all gene combinations for the stomach adenocarcinoma, color-
ectal adenocarcinoma and oesophageal carcinoma datasets.
Hierarchical clustering revealed numerous HSPs and redox regulators
that were strongly positively and negatively correlated in all carcinoma
datasets.
The colorectal dataset showed a strong positive correlation in gene
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expression between NADPH oxidase 4 (NOX4) and numerous members
of the small HSP family, including HSPB2, HSPB5 (CRYAB), HSPB7 and
HSPB8, as well as members of the HSP40 family DNAJB5 and
DNAJC5B. NOX4 also has a strong positive correlation with HSPA12B, a
member of the HSP70 family (Fig. 1A & B). Other strong positive cor-
relations in gene expression were identified between superoxide dis-
mutase 1 (SOD1) with CCT8 and glutathione peroxidase 8 (GPX8) with
HSPB2. Peroxiredoxin 2 (PRDX2) gene expression was negatively cor-
related with DNAJC13.
In the stomach adenocarcinoma dataset, strong positive correlations
in gene expression were identified between members of the small HSP
family, including HSPB2, HSPB5 (CRYAB), HSPB6, HSPB7 and HSPB8,
as well as the HSP40 family member DNAJB5, with superoxide dis-
mutase (SOD3) (Fig. 1C & D). Glutathione peroxidase 3 (GPX3) gene
expression was strongly positive correlated with HSPB8. The only
redox/HSP combination that exhibited a noteworthy negative correla-
tion at the level of gene expression was between glutathione synthetase
(GSS) and DNAJB4.
Fig. 1. Co-expression analysis of HSPs and redox regulators in gastrointestinal tumours. Heatmaps of Spearman's rank correlation coefficient (ρ) for all HSP and redox
genes (A, C,E) and selected gene combinations (B, D,F) in the following TCGA datasets: colorectal carcinoma (A, B), stomach adenocarcinoma (C, D), oesophageal
carcinoma (E, F). In all panels, blue indicates negative ρ, red indicates positive ρ. In panels B, D and F, circle size indicates magnitude of ρ.
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Strong positive correlations in the expression of SOD3 with the ex-
pression of HSPB2, HSPB6 and HSPB7 were found in the oesophageal
carcinoma dataset (Fig. 1E & F). Gene expression of the NADPH oxidase
family members NOX4 and DUOX1 was positively correlated with ex-
pression of HSPB1 and HSPB2. Negative correlations were found be-
tween PRDX3 with both HSPB5 and HSPD1, as well as between CAT and
HSPB1.
3.2. Survival analysis of patient groups exhibiting differential expression of
HSP and redox genes
We then set to determine if there were novel predictors of overall
and disease-free survival based on combinations of HSP or redox genes,
which exhibited either high or low expression. Single gene and two-
gene survival analyses were performed.
In the oesophageal carcinoma dataset, patients exhibiting high ex-
pression of HSPD1, DNAJA1 and SEC63 all resulted in significantly
lower overall survival when compared to patients with low expression
(Fig. 2A-D). High expression of PRDX2 and GPX4 reduced the disease-
free survival significantly compared to patients with lower mRNA levels
of these genes. Furthermore, patients with higher expression of DNAJB5
and CCT4 had significantly reduced disease-free survival rates (Fig. 2E-
I). Two-gene survival analysis indicated that patients with CCT2high/
GSS high, DNAJB12 high/GSS high and DNAJC8 high/GSS high phenotypes all
exhibited poorer disease-free survival, compared to patients with
CCT2low/GSShigh, DNAJB12low/GSShigh and DNAJC8low/GSShigh expres-
sion (Fig. 5A–C).
The stomach adenocarcinoma dataset revealed that overall survival
was significantly altered as a result of differential expression of four
HSPs - CCT8, DNAJC19, GAK and SEC63 (Fig. 3B-E). Low expression of
CCT8, DNAJC19 and SEC63 significantly increased overall survival,
whereas low expression of GAK significantly decreased overall survival
(Fig. 3D). Significantly poorer disease-free survival rates were found in
patients with high DNAJA4, DNAJC13 and HSPA4 expression compared
to patients with low expression (Fig. 3G-I). Two-gene survival analysis
revealed significantly poorer survival in patients with CCT5high/GPX1low
expression compared to CCT5low/GPX1low expression. Conversely, pa-
tients with DNAJC7high/GPX1low expression had a significantly better
disease free survival rate than those with DNAJC7low/GPX1low expres-
sion. High expression of both CCT4 and CCT7 resulted in significantly
Fig. 2. Single gene survival analysis of HSPs and redox regulators in oesophageal carcinoma. A) Heatmap of log-rank p-values for overall survival differences of HSPs
and redox regulators in oesophageal carcinoma. Blue indicates significant (p < 0.05) survival differences, Red indicates non-significant (p > 0.05) survival dif-
ferences. Overall survival analysis for B) HSPD1high vs HSPD1low C) DNAJA1high vs DNAJA1low D) SEC63high vs SEC63low. E) Heatmap of log-rank p-values for disease-
free survival differences of HSPs and redox regulators in oesophageal carcinoma. Overall disease-free survival analysis for F) PRDX2high vs PRDX2low G) CCT4high vs
CCT4low H) DNAJB5high vs DNAJB5low I) GPX4high vs GPX4low.
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poorer survival than those with low expression of CCT4 and CCT7
(Fig. 5D–F).
The colorectal adenocarcinoma dataset revealed that the increased
expression of CCT2 resulted in a significantly decreased disease-free
survival (Fig. 4C). When two-gene survival analysis was performed
combinations of HSP and redox regulators, patients with HSPA9high/
PRDX1high, DNAJA2high/TXNhigh and DNAJA2high/PRDX6high genotypes
all had significantly decreased overall survival rates when compared to
the same combinations with low expression (Fig. 5G–I).
3.3. Correlations between gene methylation and expression at different
pathological stages
We set to determine Spearman correlation coefficients between gene
methylation and expression for 126 genes in our HSP and redox reg-
ulator set, and to draw connection between this, pathological stage and
survival (Fig. 6A-C). The majority of genes in oesophageal carcinoma
unexpectedly exhibited a negative correlation between methylation and
mRNA expression at stages T1, T2 and T3 (Fig. 6D). HSPB9 showed a
negative correlation across these stages (Fig. 6D). GPX4 demonstrated a
weak negative correlation that remained mainly unchanged across
different pathological stages. CCT6A exhibited the strongest negative
correlation at T1, which decreased with tumour stage progression.
DNAJC18 showed a strong negative correlation at T2, which progressed
to a weak negative correlation in stage T3. The loss of a strong negative
correlation during the progression of tumours suggests that there may
be decreased methylation and increased mRNA expression during the
more progressed stages. This is consistent with survival data for
DNAJC18 (Fig. S4A) and CCT6A (Fig. S4B), both of which, when highly
expressed, result in significantly poorer overall patient survival com-
pared to patients with low expression. Conversely, consistently low
negative correlations between stages in HSPB9 suggest no loss of me-
thylation and low mRNA expression, consistent with low levels of
HSPB9 reflecting significantly poorer patient survival.
When the analysis was performed on the stomach adenocarcinoma
data, a strong negative correlation between gene expression and me-
thylation was observed for DNAJA4. This correlation was stronger in
the later stages (T2, T2b, T3, T4, T4a and T4b) than in T1 (Fig. 6E). The
survival analysis revealed that patients with DNAJA4low had a sig-
nificantly poorer disease free survival than those with the DNAJA4high
Fig. 3. Single gene survival analysis of HSPs and redox regulators in stomach adenocarcinoma. A) Heatmap of log-rank p-values for overall survival differences of
HSPs and redox regulators in stomach adenocarcinoma. Blue indicates significant (p < 0.05) survival differences, Red indicates non-significant (p > 0.05) survival
differences. Overall survival analysis for B) CCT8high vs CCT8low C) DNAJC19high vs DNAJAC19low D) GAKhigh vs GAKlow E) SEC63high vs SEC63low. F) Heatmap of log-
rank p-values for disease-free survival differences of HSPs and redox regulators in stomach adenocarcinoma. Disease-free survival analysis for G) DNAJA4high vs
DNAJA4low H) DNAJC13high vs DNAJC13low I) HSPA4high vs HSPA4low
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phenotype, suggesting that increased gene methylation of DNAJA4 may
predict poorer survival. A similar trend of a strong negative correlation
was seen in GAK in all stages (T1-T4b). Again, patients with a GAKlow
phenotype had a significantly poorer overall survival than those with a
GAKhigh phenotype, suggesting that the methylation status, corre-
sponding to overall gene expression, plays an important role in overall
patient survival.
In the colorectal dataset, two genes were identified where methy-
lation may play an important role in gene expression at different tu-
mour stages. GSTM1 exhibited a very strong negative correlation be-
tween methylation and gene expression in stages T1 through to T4a,
however, this correlation was nearly completely lost in stage T4b
(Fig. 6F). Methylation of DNAJC8 was strong negatively correlated in
stage T1, suggesting gene silencing through methylation, although in
T4a and T4b, this correlation was reversed, suggesting that methylation
was correlated with an increase in gene expression.
3.4. Gene set enrichment analysis in patient groups associated with
significantly altered survival
To determine whether the genotypes associated with differing dis-
ease-free or overall survival outcomes were also broadly associated
with other biological processes and molecular functions, we performed
gene set enrichment analysis (GSEA). The Gene Ontology (GO) gene
sets were used for this purpose. Across the three gastrointestinal tumour
types, grouped individuals with high expression of HSP family members
were, unsurprisingly, enriched in gene sets covering processes involved
in canonical HSP function, for example, protein folding, chaperone-
mediated protein folding and heat shock protein binding (Fig. 7A–C).
The colorectal adenocarcinoma dataset, which had only one statis-
tically significant survival phenotype (CCT2high vs CCT2low), was pri-
marily enriched in GO gene sets involved in mitochondrial transport
and organisation. (Fig. 7D). CCT2low individuals were enriched for gene
sets involved in clathrin-mediated endocytosis compared to CCT2high
individuals.
GSEA on the oesophageal carcinoma phenotypes associated with
differential survival outcomes were enriched in GO terms associated
with mitochondrial matrix, transport and genome maintenance (CCT4/
CCT7high vs CCT4/CCT7low), mitochondrial morphogenesis and oxi-
doreductase activity (HSPD1high vs HSPD1low) and protein localisation
to the membrane, organelles and ER (GPX4high vs GPX4low). The CCT4/
CCT7low vs CCT4/CCT7high phenotypes were enriched for gene sets
involved in the negative regulation of IL-6 production (Fig. 7E).
In the stomach adenocarcinoma dataset, GO gene sets for mi-
tochondrial membrane transport and structure, as well as mitochon-
drial respiration components, were significantly enriched. Gene sets
involved in hydrogen peroxide metabolic processes and cell redox
homeostasis were enriched in patients with a DNAJC13low vs
DNAJC13high phenotypes. HSPA9high/PRDX1high individuals were sig-
nificantly enriched in genes mediating mitochondrial respiratory chain
complex I biogenesis and protein localisation to the mitochondria,
while conversely, HSPA9low/PRDX1low individuals were significantly
enriched for gene sets involved in the negative regulation of growth.
Gene sets for mitochondrial matrix, transport and aerobic respiration
were all enriched in the CCT8high individuals, while genes mediating
negative regulation for locomotion were enriched in grouped in-
dividuals demonstrating a CCT8low phenotype (Fig. 7F).
4. Discussion
We analysed publicly available TCGA datasets from three gastro-
intestinal tumours utilising a list of 96 HSP family genes and 30 genes
that have been implicated in cellular redox functions. We analysed gene
correlations, correlations between methylation status in tumour stages
with gene expression, and overall and disease free survival in patients.
We then selected the genotypes that demonstrated significant differ-
ences in patient survival and performed gene set enrichment analysis to
reveal up or downregulated gene sets associated with these phenotypes.
The colorectal and oesophageal dataset revealed positive gene corre-
lations between NOX4 and a variety of HSP family members. NOX4 has
been previously shown to mediate the expression of HSP27mediated by
TGFβ [46]. This is in line with previous reports that have demonstrated
co-localisation of NOX4 with HSP27 and HSP70 in vascular smooth
muscle cells [47] and myoblasts [48] respectively. In all datasets,
members of the superoxide dismutase family, which are responsible for
the production of H2O2 through the dismutation of O2-, have a positive
correlation with many HSPs. This is consistent with previous
Fig. 4. Single gene survival analysis of HSPs and redox regulators in colorectal
carcinoma. A) Heatmap of log-rank p-values for overall survival differences of
HSPs and redox regulators in colorectal carcinoma. B) Heatmap of log-rank p-
values for disease-free survival differences of HSPs and redox regulators in
colorectal carcinoma. Blue indicates significant (p < 0.05) survival differ-
ences, Red indicates non-significant (p > 0.05) survival differences. C)
Disease-free survival analysis for CCT2high vs CCT2low.
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observations that have demonstrated the induction of a variety of HSPs,
including HSP30, HSP90 and HSP70, through H2O2 [49–51]. HSP70
itself directly interacts with SOD2 and may chaperone the enzyme to
the mitochondria, although the exact mechanism remains unclear [52].
Interestingly, enzymes involved in ROS detoxification, such as catalase
and peroxiredoxins, exhibited a negative correlation with HSPs. This
aligns with the observation that HSP gene expression is induced by
H2O2. Higher levels of intracellular hydrogen peroxide, as a result of
decreased catalase or peroxidredoxin expression, may facilitate cellular
redox conditions permissible for the induction of high levels of HSP
family members. Strong positive correlations were shown between
various members of the small HSP family and redox-related genes. It
has previously been shown that HSP27 plays roles in the pathological
state of cancer cells in response to oxidative stress through modulation
of the ROS-glutathione pathway [53]. HSP27 has been shown to act as a
protectant against the oxidation of proteins [53]. Overexpression of
HSP27 has also been shown to increase extracellular O2- production to
produce a pro-oxidant state beneficial for cell survival [53,54]. Fur-
thermore, phosphorylation-mediated downregulation of HSP27 was
shown to sensitize cancer cells to TRAIL-mediated apoptosis upon ex-
posure to a small molecule [55] that signals through extracellular H2O2
production [56]. These observations align with results demonstrated in
all these gastrointestinal cancer datasets.
Gene methylation is widely known to influence gene expression
[57]. We observed a strong negative correlation between DNAJA4 gene
methylation and expression in stomach adenocarcinoma, which sug-
gested that methylation of DNAJA4 may suppress gene expression. This
is consistent with reports that DNAJA4 expression is strongly influenced
by its methylation status [58]. Our data also revealed that patients with
low DNAJA4 expression had poorer survival outcomes. Together, this
data suggests that gene methylation of DNAJA4 may suppress its ex-
pression, leading to poorer patient outcomes. DNAJA4 has been shown
to promote metastasis and angiogenesis in melanoma [59], but may act
as a tumour suppressor in stomach cancer. DNAJA4 and its methylation
status may be a new biomarker for stomach adenocarcinoma, although
this may not be applicable to other carcinomas. Gene expression of GAK
(cyclin G-associated kinase) was also found to be negatively correlated
in stomach cancer, and patients with a GAKlow phenotype had poorer
overall survival. While GAK has been shown to promote oncogenesis in
some cancers [60], in stomach cancer it appears that higher expression
of GAK may be beneficial. GAK has been shown to be essential for
clathrin-mediated endocytosis [61], which, if impaired, can lead to
prolonged cell signalling and higher rates of proliferation [62]. In the
colorectal dataset, GSTM1 demonstrated a high negative correlation in
all stages prior to stage T4a, whereas in stage T4b this was completely
lost, suggesting that low levels of GSTM1 are associated with the onset
and progression of colorectal cancer. This has been confirmed in dif-
ferent populations, where the GSTM1 null variant was correlated with
increased colorectal cancer risk [63,64]. The mechanisms of GSTM1
gene methylation may provide interesting insights into the onset of
Fig. 5. Combinatorial gene survival analysis of HSPs and redox regulators in gastrointestinal cancers. Disease-free survival analysis for A) CCT4/CCT7high vs CCT4/
CCT7low, B) CCT5/GPX1high vs CCT5/GPX1low C) DNAJC7/GPX1high vs DNAJC7/GPX1low in oesophageal carcinoma dataset. Overall survival analysis for D) HSPA9/
PRDX1high vs HSPA9/PRDX1low E) DNAJA2/TXNhigh vs DNAJA2/TXNlow and F) DNAJA2/PRDX6high vs DNAJA2/PRDX6low in stomach adenocarcinoma dataset.
Disease-free survival analysis for G) CCT2high/GSShigh vs CCT2low/GSSlow H) DNAJB12high/GSShigh vs DNAJB12low/GSSlow I) DNAJC8high/GSShigh vs DNAJC8low/
GSSlow in colorectal carcinoma dataset.
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Fig. 6. Correlation of methylation and gene expression of HSPs and redox regulators in gastrointestinal cancers. Heatmap of Spearman's rank correlation coefficient
(ρ) for TCGA datasets of A) oesophageal carcinoma B) stomach adenocarcinoma and C) colorectal carcinoma for various tumour stages (T1-T4b). Blue indicates
negative Spearman's coefficient, Red indicates positive Spearman's coefficient. Green line indicates redox regulator genes, yellow line indicates HSP genes. D) Line
graph plotting gene methylation to mRNA expression through tumour stages T1-T3 of HSPB9, CCT6A, GPX4 and DNAJC18 for oesophageal carcinoma dataset. E)
Line graph plotting gene methylation to mRNA expression through tumour stages T1-T4b of TRAP1, DNAJC19, CCT8, DNAJA4 and GAK for stomach adenocarcinoma
dataset. F) Line graph plotting gene methylation to mRNA expression through tumour stages T1-T4b of DNAJC8, and GSTM1 for colorectal carcinoma dataset.
Fig. 7. Gene set enrichment analysis (GSEA) of HSPs and redox regulators in gastrointestinal cancers. Bar graphs of normalised enrichment scores (NES) from GSEA
of various HSPhigh vs HSPlow phenotypes in A) colorectal carcinoma B) oesophageal adenocarcinoma and C) stomach adenocarcinoma for validation of HSP related
processes. Bar graphs of normalised enrichment scores (NES) from GSEA of various redox regulatorshigh/low/HSPhigh/low vs redox regulatorshigh/low/HSPlow/high
phenotypes in D) colorectal carcinoma E) oesophageal carcinoma and F) stomach adenocarcinoma. Heat shock protein genes indicated by yellow writing, redox
regulators indicated by green writing.
S.Ö.-G. Pohl et al. Redox Biology xxx (xxxx) xxxx
8
colorectal cancer.
Our gene set enrichment data implicated many biological processes
that are crucial for tumorigenesis in these cancer types surveyed, many
being involved in mitochondrial functions, an organelle crucial in the
progression of cancer [65]. In the colorectal dataset, the CCT2high
phenotype, which displayed poorer survival, was enriched in gene sets
involved in mitochondrial organisation and membrane processes. While
CCT2 overexpression has previously been shown to adversely affect
colorectal patient survival [66], its role in mitochondrial membrane
organisation is less clearly understood. A recent study in colorectal
cancer identified CCT2 as a synthetic lethal partner to mutant KRAS,
which was found to be dependent on mitochondrial translation for
viability [67]. Similarly, in oesophageal cancer, patients with HSPD1high
and CCT4high/CCT7high phenotypes displayed enrichment for gene sets
involved in mitochondrial processes, such as organelle fission, transport
and genome maintenance, which were associated with poorer survival.
HSPD1 was identified as an enriched gene in the ESCC4 subtype of
oesophageal carcinoma, which also has the poorest survival outcomes
[68]. HSPD1 has been previously shown to be critical for mitochondrial
protein folding [69]. It also functions as a protectant against pharma-
cologically-induced oxidative stress [70]; therefore, combination
therapy that initiates oxidative stress-induced apoptosis, such as myr-
tucommulone while simultaneously inhibiting HSP60 may result in
better outcomes [71]. Glutathione peroxidase family member GPX4
protects against lipid peroxidation and ferroptosis, and is pre-
dominantly expressed in the mitochondria of the testis [72,73]. Over-
expression of GPX4 in oesophageal cancer patients correlates with the
upregulation of gene sets involved in protein localisation to the ER and
membrane, a process that, if dysregulated, can contribute to carcino-
genesis [74]. GPX4 overexpression may represent a novel biomarker
and a potential therapeutic target for the treatment of oesophageal
cancer.
The stomach adenocarcinoma dataset revealed many combinations
of HSPs and redox regulators that influenced patient survival. These
were also associated with many biological processes involved in mi-
tochondrial transport, metabolism and cellular redox homeostasis. The
overexpression of DNAJC19, which encodes for the protein TIM14, has
yet to be shown to influence oncogenesis or patient survival in stomach
cancer. It functions as a translocase on the inner mitochondrial mem-
brane [75], and GSEA on DNAJC19high patients revealed enrichment of
gene sets for mitochondrial membrane and oxidoreductase activity.
Conversely, DNAJC13 overexpression may benefit patient survival
outcomes. The primary role of DNAJC13 is in early endosome trans-
portation, [76] and in ERBB2 positive breast cancers has been im-
plicated in the trafficking of epidermal growth factor receptor (EGFR)
to the plasma membrane [77]. In this context, DNAJC13 is seen as a
potential therapeutic target, whereas the situation is reversed in sto-
mach cancer; the enriched gene sets for the DNAJC13low phenotype
primarily included cell redox homeostasis and those involved in mi-
tochondrial complexes and metabolism. Therefore, DNAJC13 depletion
may facilitate mitochondrial complex function and pro-oxidant state
necessary to promote tumorigenesis. CCT8high individuals were found
to have a significantly poorer overall survival, and interestingly, the
GSEA revealed that CCT8low individuals were enriched for gene sets
involved in the negative regulation of locomotion. This is consistent
with the reduction in cell migration and invasion observed in glioma
cells following siRNA-mediated knockdown of CCT8 [78].
This study has uncovered a variety of novel HSP and redox genes
that may influence patient outcomes and survival in gastrointestinal
cancers. This high-throughput method of data extraction and analysis
will become more valuable as more patient data becomes available.
This study also sets a foundation for the analysis and development of
multi-gene signatures that can predict patient survival, and ex-
ponentially expand our list of biomarkers for the onset and progression
of a variety of cancers.
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